Author's articles
Warsaw Stock Exchange: RELPOL Q4’22 RESULTS
Warsaw Stock Exchange: ELEKTROTIM Q4’22 RESULTS
Warsaw Stock Exchange – Enter Air – analyst comment - Q4’22 Results
Warsaw Stock Exchange: Mirbud – Valuation, relative valuation, ESG section, risk to fair value
Warsaw Stock Exchange: Mirbud - Economic slowdown means stabilizing costs
Sygnity: Key risks, Valuation and DCF valuation – Warsaw Stock Exchange
Sygnity: sell (reiterated). Workable Strategy and Expensive Multiples
BioMaxima - 4Q22 financial results preview
WSE: Action - Event: 4Q22 financial results released – close to our forecasts.
WSE: Unimot - Event: Management outlook, following the publication of 4Q22 results
WSE: Unimot - Event: 4Q22 results revealed; Adjusted EBITDA close to the preliminary figures published earlier
WSE: Unimot - PLN 13.69 per share dividend proposed from FY22 profits
Warsaw Stock Exchange: Bioton - strong exports
Warsaw Stock Exchange: MCI Capital - the worst is already priced in?
Warsaw Stock Exchange: DataWalk - 4Q22 final results released – close to preliminary figures
Warsaw Stock Exchange: Ryvu Therapeutics – Valuation
Ryvu Therapeutics: Termination of partnering deal with Galapagos, Valuation summary and more
Ryvu Therapeutics: Milestones payments from Exelixis, Share issue and 4Q22 results & Conference highlights
